CA
CA · CA · CA-DIN-02412683
NAGLAZYME
ATC A16AB08
Last synced from Health Canada Drug Product Database (Canada) on
Identification
ManufacturerBIOMARIN PHARMACEUTICAL INC.
CountryCA (CA)
ATC codeA16AB08
Dispensing—
ReimbursedNo
SourceHealth Canada Drug Product Database (Canada)
Last synced6/11/2026
Packs · 0
No packs registered.
Annotations
No annotations yet.
Raw payload (JSON)
{
"din": "02412683",
"form": "SOLUTION",
"class": "Human",
"routes": [
"INTRAVENOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "A16AB08",
"schedule": [
"Prescription",
"Schedule D"
],
"drug_code": "89735",
"strengths": [
"1 MG"
],
"ahfs_class": null,
"substances": [
"GALSULFASE"
],
"product_categorization": null
}Related drugs
Other records sharing ATC code A16AB08.
- NONaglazymeBioMarin International Limited
- PLNaglazymeBioMarin International Ltd.
- 🇨🇭NaglazymeDRAC AG
- DKNaglazymeBioMarin International Limited
- ISNaglazymeBioMarin International Limited
- FINaglazymeBiomarin International Limited
- CZNAGLAZYMEBioMarin International Limited, Dublin
- 🇺🇸NAGLAZYMEBioMarin Pharmaceutical Inc.
Access this data programmatically
Query NAGLAZYME and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.